Antiobesity Market Report 2026
Download Free Sample Buy Now
Antiobesity Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Antiobesity Market Report 2026

Global Outlook – By Drug Class (Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs ), By Type (Prescription Drugs (Rx), OTC Drugs ), By Medication (Monotherapies, Polytherapies ) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Antiobesity Market Overview

• Antiobesity market size has reached to $4.1 billion in 2025

• Expected to grow to $6.56 billion in 2030 at a compound annual growth rate (CAGR) of 10%

• Growth Driver: Rising Prevalence Rate Of Obesity Driving Market Growth Due To Increased Need For Effective Weight Management Therapies

• Market Trend: Embedding Dual GIP/GLP-1 Agonists for Enhanced Weight Loss and Metabolic Control

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Antiobesity Market?

The anti-obesity drugs refer to the medications that are used to lower or regulate weight of a patient. These drugs interfere with one of the body's basic functions, controlling weight, by affecting either appetite or calorie absorption. Dieting (a healthy diet and caloric restriction) and exercise continue to be the main therapeutic approaches for overweight and obese people.

The main classes of drugs in anti-obesity are peripherally acting anti-obesity drugs and centrally acting anti-obesity drugs. Antiobesity medications with a peripheral effect help people lose weight without influencing the brain or decreasing their appetite. It blocks pancreatic lipase and hinders fat breakdown in the gastrointestinal tract, lowering fat absorption through the intestine. The different types of drugs include prescription drugs (Rx), and OTC drugs and involve various medications such as monotherapies and polytherapy.

Antiobesity Market Global Report 2026 Market Report bar graph

What Is The Antiobesity Market Size and Share 2026?

The antiobesity market size has grown strongly in recent years. It will grow from $4.1 billion in 2025 to $4.47 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rising global obesity rates, limited success of lifestyle-only interventions, availability of appetite suppressants, growing metabolic disorder burden, physician-led weight management.

What Is The Antiobesity Market Growth Forecast?

The antiobesity market size is expected to see rapid growth in the next few years. It will grow to $6.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing prevalence of diabetes and obesity, innovation in hormone-based drugs, expansion of reimbursement coverage, rising obesity awareness, demand for sustainable weight loss solutions. Major trends in the forecast period include rapid adoption of glp-1 based therapies, growing preference for prescription weight loss drugs, increasing use of combination antiobesity therapies, rising focus on long-term weight management, expansion of obesity treatment access.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Antiobesity Market Segmentation

1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs

2) By Type: Prescription Drugs (Rx), OTC Drugs

3) By Medication: Monotherapies, Polytherapies

Subsegments:

1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin

2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide

What Is The Driver Of The Antiobesity Market?

The rising prevalence rate of obesity is anticipated to propel the growth of the anti-obesity drugs market going forward. Obesity is a chronic metabolic condition characterized by excessive body fat accumulation that increases the risk of serious health complications, including diabetes, cardiovascular diseases, osteoarthritis, and certain cancers. The rising prevalence of obesity is due to increasing consumption of ultra-processed foods that are high in sugars, unhealthy fats, and refined carbohydrates, combined with sedentary lifestyles that reduce physical activity. This surge in obesity prevalence is increasing the need for effective antiobesity medical interventions, supportive weight management therapies, and long-term treatment solutions to mitigate associated health risks and improve patient outcomes. For instance, in March 2024, according to the World Obesity Federation, a UK-based organization focused on obesity research and advocacy, 79% of adults with overweight and obesity and 88% of children with overweight and obesity are projected to be living in low and middle income countries by 2035. Therefore, the rising prevalence rate of obesity is driving the growth of the anti-obesity drugs market.

Key Players In The Global Antiobesity Market

Major companies operating in the antiobesity market are Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd.

Global Antiobesity Market Trends and Insights

Major companies operating in the antiobesity market are focusing on product innovation and formulation such as dual glucose-dependent insulinotropic peptide receptor agonists, to provide more effective weight loss, improved metabolic outcomes, and better tolerability. These therapies leverage synergistic actions on appetite suppression, insulin sensitivity, and energy expenditure to deliver superior efficacy compared to earlier generation GLP-1-only treatments. For instance, in December 2024, Eli Lilly, a US-based pharmaceutical company, received FDA approval for Zepbound (tirzepatide), making it the first and only prescription dual GIP/GLP-1 agonist approved for chronic weight management. Tirzepatide has demonstrated robust weight-loss efficacy, with phase 3 trial participants achieving significant reductions in body weight. With its new indication, Zepbound is expected to reinforce Lilly’s leadership in the precision obesity therapy space, catering to the growing demand for long-acting, high-efficacy treatments.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Antiobesity Market?

In August 2023, Eli Lilly, a US-based pharmaceutical company, acquired Versanis Bio, for an undisclosed amount. Through this acquisition, Eli Lilly aims to strengthen its antiobesity drug portfolio by integrating Versanis Bio’s innovative therapies targeting metabolic and weight-management pathways, enabling the development of next-generation treatments for obesity and related metabolic disorders. Versanis Bio is a US-based biotechnology company, specializes in the development of novel therapeutics for obesity and metabolic diseases with a strong track record in preclinical and early clinical research.

Regional Insights

North America was the largest region in the anti-obesity market in 2025. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antiobesity Market?

The anti-obesity market consists of sales of liraglutide, semaglutide, naltrexone-bupropion, and orlistat. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antiobesity Market Report 2026?

The antiobesity market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antiobesity industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Antiobesity Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.47 billion
Revenue Forecast In 2035 $6.56 billion
Growth Rate CAGR of 9.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Type, Medication
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZen
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Antiobesity Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Antiobesity Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Antiobesity Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Antiobesity Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rapid Adoption Of Glp-1 Based Therapies

4.2.2 Growing Preference For Prescription Weight Loss Drugs

4.2.3 Increasing Use Of Combination Antiobesity Therapies

4.2.4 Rising Focus On Long-Term Weight Management

4.2.5 Expansion Of Obesity Treatment Access

5. Antiobesity Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Weight Management Clinics

5.3 Endocrinology Clinics

5.4 Retail Pharmacies

5.5 Specialty Care Centers

6. Antiobesity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Antiobesity Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Antiobesity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Antiobesity Market Size, Comparisons And Growth Rate Analysis

7.3. Global Antiobesity Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Antiobesity Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Antiobesity Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Antiobesity Market Segmentation

9.1. Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs

9.2. Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription Drugs (Rx), OTC Drugs

9.3. Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monotherapies, Polytherapies

9.4. Global Antiobesity Market, Sub-Segmentation Of Peripherally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Orlistat, Lorcaserin

9.5. Global Antiobesity Market, Sub-Segmentation Of Centrally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide

10. Antiobesity Market Regional And Country Analysis

10.1. Global Antiobesity Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Antiobesity Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Antiobesity Market

11.1. Asia-Pacific Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Antiobesity Market

12.1. China Antiobesity Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Antiobesity Market

13.1. India Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Antiobesity Market

14.1. Japan Antiobesity Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Antiobesity Market

15.1. Australia Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Antiobesity Market

16.1. Indonesia Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Antiobesity Market

17.1. South Korea Antiobesity Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Antiobesity Market

18.1. Taiwan Antiobesity Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Antiobesity Market

19.1. South East Asia Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Antiobesity Market

20.1. Western Europe Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Antiobesity Market

21.1. UK Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Antiobesity Market

22.1. Germany Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Antiobesity Market

23.1. France Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Antiobesity Market

24.1. Italy Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Antiobesity Market

25.1. Spain Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Antiobesity Market

26.1. Eastern Europe Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Antiobesity Market

27.1. Russia Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Antiobesity Market

28.1. North America Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Antiobesity Market

29.1. USA Antiobesity Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Antiobesity Market

30.1. Canada Antiobesity Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Antiobesity Market

31.1. South America Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Antiobesity Market

32.1. Brazil Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Antiobesity Market

33.1. Middle East Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Antiobesity Market

34.1. Africa Antiobesity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Antiobesity Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Antiobesity Market Regulatory and Investment Landscape

36. Antiobesity Market Competitive Landscape And Company Profiles

36.1. Antiobesity Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Antiobesity Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Antiobesity Market Company Profiles

36.3.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Zafgen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Rhythm Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Antiobesity Market Other Major And Innovative Companies

Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd.

38. Global Antiobesity Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Antiobesity Market

40. Antiobesity Market High Potential Countries, Segments and Strategies

40.1 Antiobesity Market In 2030 - Countries Offering Most New Opportunities

40.2 Antiobesity Market In 2030 - Segments Offering Most New Opportunities

40.3 Antiobesity Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Antiobesity Market, Overview Of Key Products - Product Examples
  • Table 2: Global Antiobesity Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Antiobesity Market, Supply Chain Analysis
  • Table 4: Global Antiobesity Market, Major Raw Material Providers
  • Table 5: Global Antiobesity Market, Major Resource Providers
  • Table 6: Global Antiobesity Market, Major Manufacturers (Suppliers)
  • Table 7: Global Antiobesity Market, Major Distributors And Channel Partners
  • Table 8: Global Antiobesity Market, Key Technologies & Future Trends
  • Table 9: Global Antiobesity Market, Major Trends
  • Table 10: Global Antiobesity Market, Major End Users
  • Table 11: Global Antiobesity Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Antiobesity Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Antiobesity Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Antiobesity Market - TAM, US$ Billion, 2025
  • Table 15: Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Antiobesity Market, Sub-Segmentation Of Peripherally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Antiobesity Market, Sub-Segmentation Of Centrally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Antiobesity Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Antiobesity Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Antiobesity Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Antiobesity Market - Company Scoring Matrix
  • Table 96: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 97: Eisai Co. Ltd. Financial Performance
  • Table 98: Novo Nordisk A/S Financial Performance
  • Table 99: Zafgen Inc. Financial Performance
  • Table 100: Rhythm Pharmaceuticals Inc. Financial Performance
  • Table 101: Global Antiobesity Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Antiobesity Market, Competitive Dashboard
  • Table 103: Global Antiobesity Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Antiobesity Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 105: Global, Antiobesity Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 106: Global, Antiobesity Market Size Gain ($ Billion), Segmentation By Medication, 2025 – 2030

List Of Figures

    Figure 1: Global Antiobesity Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Antiobesity Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Antiobesity Market, Supply Chain Analysis
  • Figure 4: Global Antiobesity Market, Major Raw Material Providers
  • Figure 5: Global Antiobesity Market, Major Resource Providers
  • Figure 6: Global Antiobesity Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Antiobesity Market, Major Distributors And Channel Partners
  • Figure 8: Global Antiobesity Market, Key Technologies & Future Trends
  • Figure 9: Global Antiobesity Market, Major Trends
  • Figure 10: Global Antiobesity Market, Major End Users
  • Figure 11: Global Antiobesity Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Antiobesity Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Antiobesity Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Antiobesity Market - TAM, US$ Billion, 2025
  • Figure 15: Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Antiobesity Market, Sub-Segmentation Of Peripherally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Antiobesity Market, Sub-Segmentation Of Centrally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Antiobesity Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Antiobesity Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Antiobesity Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Antiobesity Market - Company Scoring Matrix
  • Figure 96: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 97: Eisai Co. Ltd. Financial Performance
  • Figure 98: Novo Nordisk A/S Financial Performance
  • Figure 99: Zafgen Inc. Financial Performance
  • Figure 100: Rhythm Pharmaceuticals Inc. Financial Performance
  • Figure 101: Global Antiobesity Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Antiobesity Market, Competitive Dashboard
  • Figure 103: Global Antiobesity Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Antiobesity Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 105: Global, Antiobesity Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 106: Global, Antiobesity Market Size Gain ($ Billion), Segmentation By Medication, 2025 – 2030

Global Oncology Precision Medicine Market Landscape: Trends and Market Share to 2029

Read More About Global Oncology Precision Medicine Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Oral Antidiabetic Drugs Industry Through 2029

Read More About Competitive and Market Trend Analysis of Oral Antidiabetic Drugs Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Orally Disintegrating Tablet Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Orally Disintegrating Tablet Industry

Global Insights: Over-The-Counter (OTC) Artificial Tears Market Expected to Surpass $6.19 Billion by 2029

Read More About Global Insights: Over-The-Counter (OTC) Artificial Tears Market Expected to Surpass $6.19 Billion by 2029

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Antiobesity Market Report 2026 - Global Outlook – By Drug Class (Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs ), By Type (Prescription Drugs (Rx), OTC Drugs ), By Medication (Monotherapies,...

Antimony Market Report 2026 - Global Outlook – By Type (Antimony Trioxide, Antimony Pentoxide, Alloys, Metal Ingots, Other Types), By Application (Flame retardant, Plastic additives, Lead acid batteries, Glass And cerami...

Fresh Compressed Yeast Market Report 2026 - Global Outlook – By Product Type (Baker’s Fresh Compressed Yeast, Brewer’s Fresh Compressed Yeast), By Form (Fresh Compressed Block Yeast, Fresh Crumbled Or Cake Yeast), By App...

Anticoagulants Market Report 2026 - Global Outlook – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagula...

Geotourism Market Report 2026 - Global Outlook – By Tour Type (Individual Travel, Professional Groups, Group Travels), By Tourism Type (Sustainable Tourism, Urban Geo-Tourism, Rural Geo-Tourism, Natural Tourism, Eco Geo-...

Blockchain In Retail Market Report 2026 - Global Outlook – By Component (Platform Or Solutions, Services), By Providers (Application Providers, Middleware Providers, Infrastructure Providers), By Application (Compliance ...

Bifurcation Lesions Market Report 2026 - Global Outlook – By Type (One-Stent, Two-Stent), By Application (Coronary Vascular, Peripheral Vascular), By End-User (Hospitals & Cardiac Care Centers, Ambulatory Surgical Center...

Artificial Lift System Market Report 2026 - Global Outlook – By Type (ESP, PCP, Gas Lift, Rod lift, Other Types), By Mechanism (Pump Assisted, Gas Assisted), By Application (Onshore, Offshore), By Well Type (Horizontal, ...

Frequently Asked Questions

The Antiobesity market was valued at $4.1 billion in 2025, increased to $4.47 billion in 2026, and is projected to reach $6.56 billion by 2030.

The global Antiobesity market is expected to grow at a CAGR of 10.0% from 2026 to 2035 to reach $6.56 billion by 2035.

Some Key Players in the Antiobesity market Include, Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therape

Major trend in this market includes: Embedding Dual GIP/GLP‑1 Agonists for Enhanced Weight Loss and Metabolic Control. For further insights on this market. request a sample here

North America was the largest region in the anti-obesity market in 2025. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, South East As

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us